Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 4, 2003, Pages 821-831

  Marshall, Neil J ^a   Andruszkiewicz, Ryszard ^b   Gupta, Sona ^a   Milewski, Sławomir ^b   Payne, John W ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

^b GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Cell wall biosynthesis; Molecular modelling; Molecular recognition; Peptide transport

Indexed keywords

(4 METHOXYFUMARAMOYL) 2,4 DIAMINOBUTANOIC ACID DERIVATIVE; (4 METHOXYFUMAROYL) 2,3 DIAMINOPROPANOIC ACID DERIVATIVE; (FUMARAMOYL) 2,4 DIAMINOPROPANOIC ACID DERIVATIVE; ALAFOSFALIN; ANTIBIOTIC AGENT; CARRIER PROTEIN; GLUTAMINE DERIVATIVE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; MUTANT PROTEIN; PRODRUG; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG CONFORMATION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME PURIFICATION; ESCHERICHIA COLI; MEMBRANE TRANSPORT; MOLECULAR MODEL; MOLECULAR RECOGNITION; MOLECULAR SIZE; NONHUMAN; PROTEIN BINDING; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; BINDING, COMPETITIVE; CARRIER PROTEINS; ESCHERICHIA COLI; GLUTAMINE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; PEPTIDES; PRODRUGS; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0242684600     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg170     Document Type: Article

References (34)

1. Chmara, H., Andruszkiewicz, R. & Borowski, E. (1986). Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium, Lt2 by fumaroyl diaminopropanoic acid-derivatives, a novel group of glutamine analogs. Biochimica et Biophysica Acta 870, 357-66.
2. Badet, B., Vermoote, P., Haumont, P. Y., Lederer, F. & LeGoffic, F. (1987). Glucosamine synthetase from Escherichia coli: purification, properties and glutamine-utilizing site location. Biochemistry 26, 1940-8.
3. Andruszkiewicz, R., Chmara, H., Milewski, S. & Borowski, E. (1987). Synthesis and biological properties of N-3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid dipeptides, a novel group of antimicrobial agents. Journal of Medicinal Chemistry 30, 1715-9.
4. Andruszkiewicz, R., Chmara, H., Milewski, S., Kasprzak, L. & Borowski, E. (1993). Structural determinants of inhibitory activity of N-3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid towards glucosamine-6-phosphate synthase. Polish Journal of Chemistry 67, 673-83.
5. Kucharczyk, N., Denisot, M. A., LeGoffic, F. & Badet, B. (1990). Glucosamine-6-phosphate synthase from Escherichia coli - determination of the mechanism of inactivation by N-3-fumaroyl-L-2,3-diaminopropionic derivatives. Biochemistry 29, 3668-76.
6. Milewski, S., Andruszkiewicz, R., Kasprzak, L., Mazerski, J., Mignini, F. & Borowski, E. (1991). Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase. Antimicrobial Agents and Chemotherapy 35, 36-43.
7. Payne, J. W. (1995). Bacterial peptide permeases as a drug delivery target. In Peptide Based Drug Design: Controlling Transport and Metabolism (Taylor, M. D. & Amidon, G. L., Eds), pp. 341-67. American Chemical Society, Washington, DC, USA.
8. Chmara, H., Milewski, S., Andruszkiewicz, R., Mignini, F. & Borowski, E. (1998). Antibacterial action of dipeptides containing an inhibitor of glucosamine-6-phosphate isomerase. Microbiology 144, 1349-58.
9. Andruszkiewicz, R., Milewski, S., Zieniawa, T. & Borowski, E. (1990). Anticandidal properties of N-3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides. Journal of Medicinal Chemistry 33, 132-5.
10. Milewski, S., Chmara, H., Andruszkiewicz, R., Borowski, E., Zaremba, M. & Borowski, J. (1988). Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase. Drugs under Experimental and Clinical Research 14, 461-5.
11. Milewski, S., Mignini, F., Micossi, L. & Borowski, E. (1998). Anti-histoplasmal in vitro and in vivo effect of Lys-Nva-FMDP. Medical Mycology 36, 177-80.
12. Payne, J. W., Grail, B. M. & Marshall, N. J. (2000). Molecular recognition templates of peptides: driving force for the molecular evolution of peptide transporters. Biochemical and Biophysical Research Communications 267, 283-9.
13. Payne, J. W., Marshall, N. J., Grail, B. M. & Gupta, S. (2002). Conformer profiles and biological activities of peptides. Current Organic Chemistry 6, 1221-46.
14. Payne, J. W., Grail, B. M., Gupta, S., Ladbury, J. E., Marshall, N. J., O'Brien, R. et al. (2000). Structural basis for recognition of dipeptides by peptide transporters. Archives of Biochemistry and Biophysics 384, 9-23.
15. Grail, B. M. & Payne, J. W. (2000). Predominant torsional forms adopted by dipeptide conformers in solution: parameters for molecular recognition. Journal of Peptide Science 6, 186-99.
16. Marshall, N. J., Grail, B. M. & Payne, J. W. (2001). Predominant torsional forms adopted by oligopeptide conformers in solution: parameters for molecular recognition. Journal of Peptide Science 7, 175-89.
17. Payne, J. W. & Marshall, N. J. (2001). Peptide Transport. In Microbial Transport Systems (Winkelman, G., Ed.), pp. 139-64. Wiley-VCH, Weinheim, Germany.
18. Smith, M. W., Tyreman, D. R., Payne, G. M., Marshall, N. J. & Payne, J. W. (1999). Substrate specificity of the periplasmic dipeptide-binding protein from Escherichia coli: experimental basis for the design of peptide prodrugs. Microbiology 145, 2891-901.
19. Andrews, J. M. (2001). BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 43-57.
20. Grail, B. M. & Payne, J. W. (2002). Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, β-lactam antibiotics and antibiotic resistance mechanisms. Journal of Molecular Recognition 15, 113-25.
21. Marshall, N. J. & Payne, J. W. (2001). The importance of electrostatic charge and dielectric constant in conformational analysis of biologically active dipeptides. Journal of Molecular Modelling 7, 112-9.
22. Payne, J. W. & Smith, M. W. (1994). Peptide transport by microorganisms. Advances in Microbial Physiology 36, 1-80.
23. Tyreman, D. R., Smith, M. W., Marshall, N. J., Payne, G. M., Schuster, C. M., Grail, B. M. et al. (1998). Peptides as prodrugs: the smugglin concept. In Peptides in Mammalian Protein Metabolism: Tissue Utilization and Clinical Targeting (Grimble, B. M. & Backwell, F. R. C., Eds), pp. 141-57. Portland Press, London, UK.
24. Payne, J. W., Payne, G. M., Gupta, S., Marshall, N. J. & Grail, B. M. (2001). Conformational limitations of glycylsarcosine as a prototypic substrate for peptide transporters. Biochimica et Biophysica Acta 1514, 65-75.
25. Brandsch, M., Knutter, F., Thunecke, F., Hartrodt, B., Born, I., Borner, V. et al. (1999). Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter. European Journal of Biochemistry 266, 502-8.
26. Ringrose, P. S. (1985). Peptides as antimicrobial agents. In Scientific Basis of Antimicrobial Chemotherapy (Greenwood, D. & O'Grady, F., Eds), pp. 219-66. Cambridge University Press, Cambridge, UK.
27. Taylor, M. D. & Amidon, G. L. (Eds) (1995). Peptide Based Drug Design: Controlling Transport and Metabolism. American Chemical Society, Washington, DC, USA.
28. Doring, F., Will, J., Amasheh, S., Clauss, W., Ahlbrecht, H. & Daniel, H. (1998). Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. Journal of Biological Chemistry 273, 23211-8.
29. Bailey, P. D., Boyd, C. A. R., Bronk, J. R., Collier, I. D., Meredith, D., Morgan, K. M. et al. (2000). How to make drugs orally active: a substrate template for peptide transporter PepT1. Angewandte Chemie International Edition 39, 506-8.
30. Davies, T. G., Hubbard, R. E. & Tame, J. R. H. (1999). Relating structure to thermodynamics: the crystal structures and binding affinity of eight OppA-peptide complexes. Protein Science 8, 1432-44.
31. Dunten, P. & Mowbray, S. L. (1995). Crystal structure of the dipeptide binding protein from Escherichia coli involved in active transport and chemotaxis. Protein Science 4, 2327-34.
32. Sleigh, S. H., Seavers, P. R., Wilkinson, A. J., Ladbury, J. E. & Tame, J. R. H. (1999). Crystallographic and calorimetric analysis of peptide binding to OppA protein. Journal of Molecular Biology 291, 393-415.
33. Tame, J. R. H., Sleigh, S. H., Wilkinson, A. J. & Ladbury, J. E. (1996). The role of water in sequence-independent ligand binding by an oligopeptide transporter protein. Nature Structural Biology 3, 998-1001.
34. Gupta, S. & Payne, J. W. (2001). Evaluation of the conformational propensities of peptide bond analogues as a basis for selecting bioactive peptidomimetics. Journal of Peptide Research 58, 546-62.